Helena Kyunghee Kim1, Ana Cristina Andreazza2, Pok Yik Yeung1, Cameron Isaacs-Trepanier3, L Trevor Young2. 1. Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Ont., Canada. 2. Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Ont. and The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ont., Canada. 3. Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ont., Canada.
Abstract
BACKGROUND: Increased oxidative stress is strongly implicated in bipolar disorder (BD), where protein oxidation, lipid peroxidation and oxidative damage to DNA have been consistently reported. High levels of dopamine (DA) in mania are also well-recognized in patients with BD, and DA produces reactive oxygen species and electron-deficient quinones that can oxidize proteins when it is metabolized. METHODS: Using immunohistochemistry and acceptor photobleaching Förster resonance energy transfer (FRET), we examined oxidation and nitration of areas immunoreactive for the DA transporter (DAT) and tyrosine hydroxylase (TH) in the postmortem prefrontal cortex from patients with BD, schizophrenia and major depression as well as nonpsychiatric controls. RESULTS: We found increased oxidation of DAT-immunoreactive regions in patients with BD (F3,48 = 6.76, p = 0.001; Dunnett post hoc test p = 0.001) and decreased nitration of TH-immunoreactive regions in both patients with BD (F3,45 = 3.10, p = 0.036; Dunnett post hoc test p = 0.011) and schizophrenia (p = 0.027). On the other hand, we found increased global levels of oxidation in patients with BD (F3,44 = 6.74, p = 0.001; Dunnett post hoc test p = 0.001) and schizophrenia (p = 0.020), although nitration levels did not differ between the groups (F3,46 = 1.75; p = 0.17). LIMITATIONS: Limitations of this study include the use of postmortem brain sections, which may have been affected by factors such as postmortem interval and antemortem agonal states, although demographic factors and postmortem interval were accounted for in our statistical analysis. CONCLUSION: These findings suggest alterations in levels of protein oxidation and nitration in DA-rich regions of the prefrontal cortex in patients with BD and schizophrenia, but more markedly in those with BD.
BACKGROUND: Increased oxidative stress is strongly implicated in bipolar disorder (BD), where protein oxidation, lipid peroxidation and oxidative damage to DNA have been consistently reported. High levels of dopamine (DA) in mania are also well-recognized in patients with BD, and DA produces reactive oxygen species and electron-deficient quinones that can oxidize proteins when it is metabolized. METHODS: Using immunohistochemistry and acceptor photobleaching Förster resonance energy transfer (FRET), we examined oxidation and nitration of areas immunoreactive for the DA transporter (DAT) and tyrosine hydroxylase (TH) in the postmortem prefrontal cortex from patients with BD, schizophrenia and major depression as well as nonpsychiatric controls. RESULTS: We found increased oxidation of DAT-immunoreactive regions in patients with BD (F3,48 = 6.76, p = 0.001; Dunnett post hoc test p = 0.001) and decreased nitration of TH-immunoreactive regions in both patients with BD (F3,45 = 3.10, p = 0.036; Dunnett post hoc test p = 0.011) and schizophrenia (p = 0.027). On the other hand, we found increased global levels of oxidation in patients with BD (F3,44 = 6.74, p = 0.001; Dunnett post hoc test p = 0.001) and schizophrenia (p = 0.020), although nitration levels did not differ between the groups (F3,46 = 1.75; p = 0.17). LIMITATIONS: Limitations of this study include the use of postmortem brain sections, which may have been affected by factors such as postmortem interval and antemortem agonal states, although demographic factors and postmortem interval were accounted for in our statistical analysis. CONCLUSION: These findings suggest alterations in levels of protein oxidation and nitration in DA-rich regions of the prefrontal cortex in patients with BD and schizophrenia, but more markedly in those with BD.
Authors: Samira S Valvassori; Gislaine T Rezin; Camila L Ferreira; Morgana Moretti; Cinara L Gonçalves; Mariana R Cardoso; Emílio L Streck; Flávio Kapczinski; João Quevedo Journal: J Psychiatr Res Date: 2010-03-23 Impact factor: 4.791
Authors: Benicio N Frey; Samira S Valvassori; Gislaine Z Réus; Márcio R Martins; Fabrícia C Petronilho; Katrine Bardini; Felipe Dal-Pizzol; Flávio Kapczinski; João Quevedo Journal: J Psychiatry Neurosci Date: 2006-09 Impact factor: 6.186
Authors: Ana C Andreazza; Marcia Kauer-Sant'anna; Benicio N Frey; David J Bond; Flavio Kapczinski; L Trevor Young; Lakshmi N Yatham Journal: J Affect Disord Date: 2008-06-09 Impact factor: 4.839
Authors: Helena K Kim; Cameron Isaacs-Trepanier; Nika Elmi; Stanley I Rapoport; Ana C Andreazza Journal: J Psychiatr Res Date: 2016-02-06 Impact factor: 4.791
Authors: Samira Menegas; Camila L Ferreira; José Henrique Cararo; Fernanda F Gava; Gustavo C Dal-Pont; Maria L Gomes; Jotele F Agostini; Patrícia Fernanda Schuck; Giselli Scaini; Monica L Andersen; João Quevedo; Samira S Valvassori Journal: Metab Brain Dis Date: 2019-03-27 Impact factor: 3.584
Authors: Małgorzata Kiełczykowska; Joanna Kocot; Jacek Kurzepa; Anna Lewandowska; Renata Żelazowska; Irena Musik Journal: Biol Trace Elem Res Date: 2014-03-28 Impact factor: 3.738
Authors: Erik A Fraunberger; Gustavo Scola; Victoria L M Laliberté; Angela Duong; Ana C Andreazza Journal: Oxid Med Cell Longev Date: 2015-11-10 Impact factor: 6.543